Is the blood B-cell subset profile diagnostic for Sjögren syndrome?
- EA Immunologie et Pathologie, Université Européenne de Bretagne, et Université de Bretagne Occidentale, Brest, et Centre Hospitalier Universitaire de Brest, Brest, France
- Correspondence to Professor P Youinou, Laboratory of Immunology, Brest University Medical School Hospital, BP 824, F29609 Brest, France; youinou{at}univ-brest.fr
- Accepted 22 August 2008
- Published Online First 9 September 2008
Abstract
Objective: To evaluate the relevance of the blood B-cell subset profile for the diagnosis of Sjögren syndrome.
Methods: The distribution of mature blood B cells from Bm1 through Bm5 was determined in 161 patients, of whom 25 fulfilled the American–European Consensus Group criteria for primary SS (pSS), and 136 served as disease controls.
Results: The percentage of Bm2 and Bm2′ cells was increased in the patients with pSS compared with 54 patients with rheumatoid arthritis (RA) and 18 with systemic lupus erythematosus (SLE) (p<0.001 for the two comparisons). In contrast, those of early Bm5 (eBm5) and Bm5 were decreased in patients with pSS, compared with patients with RA and with SLE (p<0.001 for the two comparisons). The receiver operating characteristic curves allowed for an optimising cut-off value of Bm2+Bm2′ cells at 71.1% for 88.0% sensitivity and 83.1% specificity, that of eBm5+Bm5 cells at ≤13.5% for 84.0% sensitivity and 83.1% specificity, and, consequently, that of Bm2+Bm2′/eBm5+Bm5 at ≥5 for 88.0% sensitivity and 84.6% specificity.
Conclusion: Given its presentation as a signature for pSS, relative to RA and SLE, such a distribution of B-cell subsets might provide a useful diagnostic tool.
Footnotes
-
Funding This work was funded in part by the Association Française du Gougerot-Sjögren et des syndromes secs, and by the Institut Français pour la Recherche Odontologique.
-
Competing interests None.








